Assessing the relationship in relapsed-refractory multiple myeloma between response, progression, and survival between pooled clinical trial subjects and a real-world electronic medical record data source.

被引：0
|
作者：
Watson, Mark Layton
Hurmiz, Charlie
Smith, Jordan
Marada, Suresh
Galaznik, Aaron
Diamond, Sheila
Fields, Bryant
Davi, Ruthanna
机构：
[1] Guardian Res Network Inc, Spartanburg, SC USA
[2] Medidata Solut, New York, NY USA
[3] Medidata Solut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20525
引用
收藏
页数：2
相关论文
共 11 条
  • [1] Estimating Relationships between Response, Progression, and Survival in Relapsed-Refractory Multiple Myeloma in Pooled Clinical Trials Database
    Galaznik, Aaron
    Rusli, Emelly
    Davi, Ruthanna
    BLOOD, 2019, 134
  • [2] Racial Differences in Multiple Myeloma Survival and Treatment Using Pooled Clinical Trial and Real-World Electronic Medical Record Data
    Rusli, Emelly
    Diao, Lihong
    Liu, Cynthia
    Kelkar, Mona A.
    Ensign, Lisa
    Watson, Mark
    Galaznik, Aaron
    BLOOD, 2020, 136
  • [3] Augmentation of Real-World Mortality Data in the Electronic Medical Record: Assessing the Impact on Overall Survival Estimates in Multiple Myeloma
    Liu, Pei
    Lan, Ziyu
    Walker, Brigham
    Ray, Herman E.
    Smith, Helen
    BLOOD, 2023, 142
  • [4] Treatment Sequencing in Patients with Relapsed/Refractory Multiple Myeloma after Daratumumab Treatment: Real-World Findings from a Pooled Data Analysis of Preamble and the Mckesson Electronic Medical Record Database
    Vij, Ravi
    Chen, Clara
    Yasenchak, Christopher A.
    Davis, Catherine
    Kuter, David J.
    BLOOD, 2018, 132
  • [5] Real-World and Clinical Trial Data in Relapsed/Refractory Multiple Myeloma (RRMM): Evaluating Treatment Duration and Comparing Effectiveness and Efficacy
    Richardson, Paul G.
    San Miguel, Jesus F.
    Moreau, Philippe
    Hajek, Roman
    Dimopoulos, Meletios A.
    Palumbo, Antonio
    Luptakova, Katarina
    Skacel, Tomas
    Kumar, Shaji K.
    Anderson, Kenneth C.
    BLOOD, 2017, 130
  • [6] Developing a de-Novo Mortality Model for Relapsed and Refractory Multiple Myeloma: Emulation of Subjective Life Expectancy Criteria from a Clinical Trial in Real-World Data
    Breskin, Alexander
    Spin, Paul
    Wang, Di
    Ma, Qiufei
    Kroog, Glenn S.
    Hampp, Christian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 64 - 64
  • [7] Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
    Yael C. Cohen
    Hila Magen
    Noa Lavi
    Moshe E. Gatt
    Evgeni Chubar
    Nethanel Horowitz
    Natalia Kreiniz
    Tamar Tadmor
    Svetlana Trestman
    Roy Vitkon
    Ory Rouvio
    Olga Shvetz
    Adir Shaulov
    Tomer Ziv-Baran
    Irit Avivi
    Annals of Hematology, 2020, 99 : 1273 - 1281
  • [8] Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
    Cohen, Yael C.
    Magen, Hila
    Lavi, Noa
    Gatt, Moshe E.
    Chubar, Evgeni
    Horowitz, Nethanel
    Kreiniz, Natalia
    Tadmor, Tamar
    Trestman, Svetlana
    Vitkon, Roy
    Rouvio, Ory
    Shvetz, Olga
    Shaulov, Adir
    Ziv-Baran, Tomer
    Avivi, Irit
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1273 - 1281
  • [9] Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy
    Mcgough, Sarah F.
    Shamas, Natasha
    Wang, Jue
    Jaber, Mahmoud
    Swarup, Binay
    Zumofen, Marie-Helene Blanchet
    Lautie, Bertrand
    Parreira, Joana
    Wei, Michael C.
    Shewade, Ashwini
    LEUKEMIA & LYMPHOMA, 2023, 64 (14) : 2269 - 2278
  • [10] Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial Data
    Cartier, Shannon
    Zhang, Bin
    Rosen, Virginia M.
    Zarotsky, Victoria
    Bartlett, J. Blake
    Mukhopadhyay, Pralay
    Wagner, Samuel
    Davis, Catherine
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (03) : 88 - 94
12